Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPM4 | Q8TD43 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | LPL | P06858 | 1/20 | 0.31 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10046440 | 0.82 | ALDH1A1 (0.32) | ALDH1A1MAPT | |
| SCHEMBL11997329 | 0.82 | L3MBTL1 (0.32) | ALDH1A1HSD17B10LPLLIPGMAPT | |
| SCHEMBL734336 | 0.78 | LPL (0.45) | TRPM4ALDH1A1HIF1ACYP1B1HSD17B10 | |
| SCHEMBL12227462 | 0.77 | CYP1A2 (0.41) | ALDH1A1HSD17B10HPGD | |
| SCHEMBL22434217 | 0.74 | ALDH1A1 (0.39) | ALDH1A1HSD17B10MAPTHPGD | |
| SCHEMBL13855220 | 0.74 | TRPM4 (0.41) | TRPM4ALDH1A1HIF1ACYP1B1HSD17B10 | |
| SCHEMBL13453879 | 0.73 | LPL (0.48) | LPLLIPG | |
| SCHEMBL13056319 | 0.73 | LPL (0.37) | LPLLIPG | |
| SCHEMBL13855744 | 0.72 | ALDH1A1 (0.38) | ALDH1A1CYP1B1HSD17B10MAPTHPGD | |
| SCHEMBL10022888 | 0.72 | LPL (0.30) | LPLLIPG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090134384-A1 | ORGANIC ELECTROLUMINESCENT DEVICE AND BORIC ACID AND BORINIC ACID DERIVATIVES USED THEREIN | MERCK PATENT GMBH (DE) | 2009-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090134384-A1 | ORGANIC ELECTROLUMINESCENT DEVICE AND BORIC ACID AND BORINIC ACID DERIVATIVES USED THEREIN | BTD, ERG, OR10J3 | TRPM4 357/4885ALDH1A1 857/4885HIF1A 3829/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.